Zoetis | ZTS - Cost Of Sales




Zoetis reported $707M in Cost of Sales for its fiscal quarter ending in December of 2024.

Cost Of Sales Change Date
AbbVie USD 4.4B 184M Dec/2024
Align Technology USD 298.28M 2.18M Dec/2024
Bayer EUR 5.09B 96M Sep/2024
Bristol-Myers Squibb USD 4.81B 1.86B Dec/2024
Charles River Laboratories USD 733.96M 91.97M Dec/2024
Dentsply International USD 456M 17M Sep/2024
Eli Lilly USD 2.4B 233M Dec/2024
Henry Schein USD 2.18B 63M Sep/2024
Idexx Laboratories USD 383.63M 4.12M Dec/2024
Illumina USD 376M 41M Dec/2024
IQVIA Holdings USD 2.58B 1.32B Dec/2024
J&J USD 6.94B 20M Dec/2024
Laboratory Of America USD 2.43B 55.5M Dec/2024
Merck USD 3.83B 579M Dec/2024
Neogen USD 117.93M 5.89M Nov/2024
Pacira USD 168.57M 122.38M Sep/2024
Patterson Companies USD 1.35B 0 Oct/2024
Perrigo USD 683.1M 12.3M Sep/2024
Pfizer USD 5.74B 480M Dec/2024
Quest Diagnostics USD 1.76B 91M Dec/2024
Sanofi EUR 4.08B 675M Sep/2024
Sanofi EUR 4.08B 675M Sep/2024
Zoetis USD 707M 6M Dec/2024